Skip to main content

MARCADORES EPIGENETICOS EN DEPRESION MAYOR: EFECTOS EN FENOTIPOS NEUROCOGNITIVOS, LA EVOLUCION CLINICA Y LA RESISTENCIA TERAPEUTICA

PI19/01040

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IDIBELL
Execution centre INSTITUTO DE INVESTIGACION BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Altered resting-state functional connectivity in individuals at risk for Alzheimer's disease, a longitudinal study

  • Chavarría-Elizondo, Pamela|||0000-0002-8177-3771
  • Maturana-Quijada, Pablo
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • del Cerro, Inés
  • Juaneda-Seguí, Asier
  • Guinea-Izquierdo, Andrés
  • Gascon Bayarri, Jordi|||0000-0002-9422-937X
  • Reñé-Ramírez, Ramón
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
  • Soriano-Mas, Carles|||0000-0003-4574-6597
Resting-state functional connectivity magnetic resonance imaging (rs-fMRI) is a sensitive tool for detecting early brain changes associated with Alzheimer's disease, even in its preclinical stages. Amnestic mild cognitive impairment (aMCI) and late-life depression (LLD) are two prevalent conditions in older adults that significantly elevate the risk of cognitive decline and dementia. This study aimed to elucidate the underlying neurobiological substrates by longitudinally identifying and comparing distinct connectivity patterns in aMCI subjects and LLD patients, and by examining the associations between these patterns and clinical measures of cognitive and mood impairments. The study included three groups: 26 healthy controls (HCs), 15 individuals with aMCI, and 21 patients with LLD. All participants underwent rs-fMRI and neuropsychological assessments at baseline and at a 2-year follow-up. Functional connectivity was analyzed using a group Independent Component Analysis (ICA) model to investigate both group differences and longitudinal changes over time. At baseline, individuals with aMCI exhibited reduced functional connectivity in the precuneus, whereas LLD patients showed decreased connectivity in frontal, insular, and postcentral regions alongside increased connectivity in posterior parietal and cuneal cortices. Correlation analyses revealed that lower baseline insular connectivity predicted higher depressive symptoms at follow-up in aMCI subjects. In LLD, reduced baseline precuneus connectivity was associated with better two-year outcomes in global cognition and long-term memory. This study provides evidence of distinct alterations in resting-state functional connectivity in individuals with aMCI and LLD, underscoring region-specific vulnerabilities that may contribute to cognitive decline and depressive symptomatology in older adults.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Relationship between immunometabolic status and cognitive performance among major depression disorder patients

  • Sánchez-Carro, Yolanda
  • Torre-Luque, Alejandro de la|||0000-0003-0595-6127
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Leal-Leturia, Itziar|||0000-0002-4384-1307
  • Salvat-Pujol, Neus|||0000-0001-5320-331X
  • Massaneda, Clara
  • De Arriba-Arnau, Aida|||0000-0002-7877-7341
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Peretó, Mar
  • Toll, Alba|||0000-0003-2399-5250
  • Martínez-Ruiz, Antonio
  • Ferreiros-Martinez, Raquel
  • Álvarez, Pilar
  • Soria, Virginia|||0000-0001-6412-6831
  • López-García, Pilar
Background: Alterations in cognitive performance have been described in patients with major depressive disorder (MDD). However, the specific risk factors of these changes are not yet known. This study aimed to explore whether inmunometabolic parameters are related to cognitive performance in MDD in comparison to healthy controls (HC) Methods: Sample consisted of 84 MDD patients and 78 HC. Both groups were compared on the results of cognitive performance measured with the Cambridge Neuropsychological Test Automated Battery (CANTAB), the presence of metabolic syndrome (MetS) and an inflammatory/oxidative index calculated by a principal component analysis of peripheral biomarkers (tumor necrosis factor, C-reactive protein and 4-hydroxynonenal). A multiple linear regression was carried out, to study the relationship between inmunometabolic variables and the global cognitive performance, being the latter the dependent variable. Results: Significant differences were obtained in the inflammatory/oxidative index between both groups (F= 12.93; p <.001), also in cognitive performance (F= 56.75; p <.001). The inmunometabolic covariate regression model (i.e., condition (HC/MDD), sex, age and medication loading, MetS, inflammatory/oxidative index and the interaction between MetS and inflammatory/oxidative index) was statistically significant (F= 11.24; p <.01) and explained 31% of variance. The condition, being either MDD or HD, (B=˗0.97; p <.001), age (B=˗0.28; p <.001) and the interaction between inflammatory/oxidative index and MetS (B=˗0.38; p =.02) were factors associated to cognitive performance. Limitations: Sample size was relatively small. The cross-sectional design of the study limits the possibilities of analysis. Conclusions: Our results provide evidence on the conjoint influence of metabolic and inflammatory dysregulation on cognitive dysfunction in MDD patients. In this way, our study opens a line of research in immunometabolic agents to deal with cognitive decline associated with MDD.